Professor Dr Edith Heard
- Section Human Genetics and Molecular Medicine
- Location Heidelberg, Germany
- Election year 2021
Research
Research Priorities: Genetics, epigenetics, developmental biology, biodiversity, planetary health
Edith Heard is a British geneticist and developmental biologist. The natural scientist has made a considerable contribution to our understanding of the epigenetic development of mammals. Her research currently focuses on the diverse range of relationships between humans and the natural world around them and how these relationships affect human health. Edith Heard is an advocate of tackling the challenges posed by climate change and the associated biodiversity loss from the perspective of the life sciences.
Heard began conducting research in epigenetics during her doctoral studies when the field was only just emerging. During her early work, she investigated the causes of gene amplification – an increase in the number of copies of the same gene – which often occurs in tumour cells. She then went on to research the epigenetic process of X-chromosome inactivation (XCI), which is where one of the two X chromosomes is largely or fully silenced during embryonic development. The scientist’s research group was one of the first to be able to demonstrate that this epigenetic process exhibits both stability and considerable plasticity.
Heard is particularly interested in researching the fundamental principles of gene regulation, especially the role of non-coding RNA during the development process and the onset of diseases.
In more recent years, she has also turned her attention to the serious global ramifications of biodiversity loss. To date, scientists have primarily focused on using physical and chemical measures to address these dramatic changes, with a tendency for the life sciences to be under-represented. Heard believes, however, that the life sciences offer much potential for us to gain an understanding of fundamental life processes from the cellular to the planetary level. In-depth knowledge about the interactions between different species could help scientists to model future developments and identify courses of action. Heard’s team is also involved in developing genomic and metabolic markers that can be used to keep a closer eye on the development of ecosystems.
As the Director General of the European Molecular Biology Laboratory (EMBL), Heard is committed to fostering close European and international cooperation. She also supports researchers working under difficult political and economic conditions in their home country or in exile.
Edith Heard is a British geneticist and developmental biologist. The natural scientist has made a considerable contribution to our understanding of the epigenetic development of mammals. Her research currently focuses on the diverse range of relationships between humans and the natural world around them and how these relationships affect human health. Edith Heard is an advocate of tackling the challenges posed by climate change and the associated biodiversity loss from the perspective of the life sciences.
Heard began conducting research in epigenetics during her doctoral studies when the field was only just emerging. During her early work, she investigated the causes of gene amplification – an increase in the number of copies of the same gene – which often occurs in tumour cells. She then went on to research the epigenetic process of X-chromosome inactivation (XCI), which is where one of the two X chromosomes is largely or fully silenced during embryonic development. The scientist’s research group was one of the first to be able to demonstrate that this epigenetic process exhibits both stability and considerable plasticity.
Heard is particularly interested in researching the fundamental principles of gene regulation, especially the role of non-coding RNA during the development process and the onset of diseases.
In more recent years, she has also turned her attention to the serious global ramifications of biodiversity loss. To date, scientists have primarily focused on using physical and chemical measures to address these dramatic changes, with a tendency for the life sciences to be under-represented. Heard believes, however, that the life sciences offer much potential for us to gain an understanding of fundamental life processes from the cellular to the planetary level. In-depth knowledge about the interactions between different species could help scientists to model future developments and identify courses of action. Heard’s team is also involved in developing genomic and metabolic markers that can be used to keep a closer eye on the development of ecosystems.
As the Director General of the European Molecular Biology Laboratory (EMBL), Heard is committed to fostering close European and international cooperation. She also supports researchers working under difficult political and economic conditions in their home country or in exile.
Career
- since 2019 Director General, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
- since 2012 Professor of Epigenetics and Cellular Memory, Collège de France, Paris, France
- since 2010 Director, Unit of Genetics and Developmental Biology, Curie Institute, Paris, France
- 2006‐2008 Senior Team Leader, Nuclear Dynamics and Genome Plasticity Unit, French National Centre for Scientific Research (CNRS), Paris, France
- 2001‐2006 Team Leader, Research Group, Curie Institute, Paris, France
- 2000‐2001 Visiting Scholar, Cold Spring Harbor Laboratory, New York City, USA
- 1993‐2000 Scientist, Laboratory of Dr. Philip Avner, Institut Pasteur, Paris, France
- 1991‐1993 Postdoctoral Fellow, Institut Pasteur, Paris, France
- 1990 Doctorate, Imperial Cancer Research Fund, Lincoln’s Inn Fields, London, UK
- 1983‐1986 Degree in Natural Sciences, University of Cambridge, Cambridge, UK
Functions
- since 2021 Member, Science Council, World Health Organization (WHO)
- since 2020 Member, Senate, Max Planck Society, Germany
- since 2017 Member, Scientific Advisory Committee, EMBL, Heidelberg, Germany
- since 2017 Member, Scientific Advisory Board, Hubrecht Institute, Utrecht, Netherlands
- since 2017 Member, Scientific Advisory Board, Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
- since 2016 Member, Scientific Advisory Board, Francis Crick Institute, London, UK
- since 2014 Member, Scientific Advisory Board, Institute of Human Genetics, Montpellier, France
- 2008 ‐ 2011 Member, Scientific Advisory Board, Young Investigator Programme, European Molecular Biology Organization (EMBO)
- 2006 ‐ 2009 Member, Scientific Advisory Board, ATIP‐Avenir Program, CNRS, Paris, France
- Chairperson, Scientific Advisory Board, Curie Institute, Paris, France
- Member, Scientific Advisory Board, CNRS, Paris, France
- Member, Strategic Research Advisory Committee, France
- Member, Membership Committee, EMBO
- Member, Committee, Fellows, Royal Society, UK
Projects
- 2016 Co‐Chair, French National Programme PAUSE, Collège de France, Paris, France
Honours and Memberships
- 2024 Croonian Medal and Lecture, Royal Society, UK
- since 2021 Member, National Academy of Medicine, USA
- since 2021 Member, German National Academy of Sciences Leopoldina, Germany
- since 2021 Member, National Academy of Sciences, USA
- 2020 L’Oréal‐UNESCO For Women in Science Award, UNESCO, L’Oréal, Paris, France
- 2019 Hansen Family Award, Bayer AG, Germany
- 2017 ESHG Award, European Society of Human Genetics (ESHG)
- 2017 Grand Prix, National Institute of Health and Medical Research (INSERM), Paris, France
- 2015 Chevalier of the French Legion of Honour, France
- since 2013 Fellow, Royal Society, UK
- since 2012 Member, Academia Europaea
- 2008 Silver Medal, CNRS, Paris, France
- 2007 Otto Mangold Award, Society of Developmental Biology, Heidelberg, Germany
- since 2005 Member, EMBO